Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novartis (Flu Vaccine Business)

M&A STATUS
401-500 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of flu vaccine products. The company is engaged in the production of vaccines for the prevention and control of seasonal influenza.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
CSL Behring
Primary Office
  • Lichtstrasse 35
  • 4056 Basel
  • Switzerland

Novartis (Flu Vaccine Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novartis (Flu Vaccine Business)‘s full profile, request access.

Request full access to PitchBook

Novartis (Flu Vaccine Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novartis (Flu Vaccine Business)‘s full profile, request access.

Request full access to PitchBook